https://www.selleckchem.com/pr....oducts/fosbretabulin
Acute Intermittent Porphyria (AIP) is a rare inherited autosomal dominant disorder of heme biosynthesis. Porphyria-associated kidney disease occurs in more than 50% of the patients with AIP, and end stage renal disease (ESRD) can be a devastating complication for AIP patients. The outcomes of AIP patients after kidney transplantation are poorly known. We examined the outcomes of 11 individuals with AIP, identified as kidney transplant recipients in the French Porphyria C
Like
Comment
Share
